OMGene Overview
OMGene integrates genetic data with artificial intelligence to create an ongoing learning decision-support system. The primary focus of the company is to optimize genetic strengths through the combination of genomics and AI proprietary models. OMGene leverages whole genome bioinformatics and behavioral genetics to analyze large genetic datasets, identifying advantageous traits. The innovative technology used by OMGene merges diverse research and dataset sources to improve organizations, career development, mental health and longevity. With a commitment to privacy and positive genetics, OMGene prioritizes data security and ethics.
Latest News
growth-positive
OMGene.AI: Using DNA and AI to identify our strengths
OMGene.AI, a new venture by Israeli venture capitalist Amir Gal-Or, is a decision-support system leveraging genetic information and AI. The project, part of the Infinity Group, has received $3 million in funding and aims to raise an additional $20 million. Initially operating as a non-profit research institute, OMGene.AI plans to transition to a commercial enterprise when the market is ready. The system analyzes DNA samples to provide personalized advice on health, social, and psychological traits. Currently employing 12 people, the venture collaborates with notable figures like Prof. Rivka Carmi and Prof. Dan Shechtman. The project also partners with the IDF for PTSD research. The company plans to market its product to organizations rather than private consumers.
InvestmentProduct StagePartners
